T1	Participants 182 239	patients undergoing coronary artery bypass graft surgery.
T2	Participants 424 507	patients undergoing isolated coronary artery bypass graft surgery from 2000 to 2008
T3	Participants 648 730	12,855 patients, of whom 7,967 (62.0%) were treated preoperatively with β-blockers
T4	Participants 793 839	4,474 patients with preoperative β-blocker use
T5	Participants 844 883	4,474 not using preoperative β-blockers
